Biotherapeutics to Modulate Bacteriome
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT06819761
Determining the Viability a Lozenge Dosage for Probiotics
Phase: Early Phase 1
Role: Lead Sponsor
Start: Mar 1, 2025
Completion: Mar 30, 2025
Loading map...